A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients

Clinical trial NCT02403440 · UNKNOWN

Trial details

NCT number: NCT02403440
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Purpura, Thrombocytopenic, Idiopathic

Start date: 2014-04-01
Primary completion: 2015-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.